z-logo
open-access-imgOpen Access
CD151—A Striking Marker for Cancer Therapy
Author(s) -
Seema Kumari,
V. Gayatri Devi,
Anil Kumar Badana,
Venkata Ramesh Dasari,
Rama Rao Malla
Publication year - 2015
Publication title -
biomarkers in cancer
Language(s) - English
Resource type - Journals
ISSN - 1179-299X
DOI - 10.4137/bic.s21847
Subject(s) - tetraspanin , metastasis , angiogenesis , cancer research , integrin , biology , carcinogenesis , cancer , cancer cell , cell , genetics
Cluster of differentiation 151 (CD151) is a member of the mammalian tetraspanin family, which is involved in diverse functions such as maintaining normal cellular integrity, cell-to-cell communication, wound healing, platelet aggregation, trafficking, cell motility and angiogenesis. CD151 also supports de novo carcinogenesis in human skin squamous cell carcinoma (SCC) and tumor metastasis. CD151 interacts with α3β1 and α6β4 integrins through palmitoylation where cysteine plays an important role in the association of CD151 with integrins and non-integrin proteins. Invasion and metastasis of cancer cells were diminished by decreasing CD151 association with integrins. CD151 functions at various stages of cancer, including metastatic cascade and primary tumor growth, thus reinforcing the importance of CD151 as a target in oncology. The present review highlights the role of CD151 in tumor metastasis and its importance in cancer therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom